ShangPharma Opens New Pilot Plant Facility

ls9idhhe0re

ShangPharma Corporation (NYSE:SHP) ("ShangPharma" or the "Company"),[link widoczny dla zalogowanych], a leading China-based pharmaceutical and biotechnology research and development outsourcing company, today announced commencement of operations on the initial phase of production at the Company’s Fengxian facility. This new multi-purpose pharmaceutical development and cGMP manufacturing facility is located in Fengxian in the suburbs of Shanghai,[link widoczny dla zalogowanych], China. The state-of-the-art facility will operate as a wholly owned subsidiary of the Company under the name of China Gateway Pharmaceutical Development Co. Ltd.,[link widoczny dla zalogowanych], and will allow the Company to expand its service offering to process research and development, formulation research and development,[link widoczny dla zalogowanych], analytical method development and validation,[link widoczny dla zalogowanych], and cGMP manufacturing of intermediates and APIs.
...